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Peter Y. Zhao1, Renata B. Filler1, Robert E. Tigelaar1 and Michael Girardi1
Cutaneous squamous cell carcinoma (SCC) is the most prevalent invasive malignancy with metastatic potential.
The epidermis is exposed to a variety of environmental DNA-damaging chemicals, principal among which are
polyaromatic hydrocarbons (PAHs) ubiquitous in the environment, tobacco smoke, and broiled meats.
Langerhans cells (LCs) comprise a network of dendritic cells situated adjacent to basal, suprabasal, and follicular
infundibular keratinocytes that when mutated can give rise to SCC, and LC-intact mice are markedly more
susceptible than LC-deficient mice to chemical carcinogenesis provoked by initiation with the model PAH, 7,12-
dimethylbenz[a]anthracene (DMBA). LCs rapidly internalize and accumulate DMBA as numerous membrane-
independent cytoplasmic foci. Repopulation of LC-deficient mice using fetal liver LC-precursors restores DMBA-
induced tumor susceptibility. LC expression of p450 enzyme CYP1B1 is required for maximal rapid induction of
DNA-damage within adjacent keratinocytes and their efficient neoplastic transformation; however, effects of
tumor progression also attributable to the presence of LC were revealed as CYP1B1 independent. Thus, LCs make
multifaceted contributions to cutaneous carcinogenesis, including via the handling and metabolism of chemical
mutagens. Such findings suggest a cooperative carcinogenesis role for myeloid-derived cells resident within
cancer susceptible epithelial tissues principally by influencing early events in malignant transformation.
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INTRODUCTION
The skin and other epithelial tissues are continually exposed to
environmental chemicals and toxins, including those with
carcinogenic potential. Mutagenic polyaromatic hydrocarbons
(PAHs), generated largely as a result of industrial combustion
exhaust and wastewater treatment discharges, have become
prevalent in the atmosphere, soil, and ground water. Auto-
mobile emissions, processed asphalt, coal burning, grilled or
charred meats, and tobacco smoke also all contribute sub-
stantially to human PAH exposure. Furthermore, a variety of
cosmetics and shampoos are made with coal tar and therefore
may contain PAHs. As lipophilic compounds, PAHs are
readily absorbed by cells; thus, PAH levels within plants and
animals may be much higher than the PAH levels detected in
their environments (ATSDR/CDC, 2011).
Skin exposure to PAHs may occur by direct contact, as
well as by distribution to the skin after systemic absorption.
People who smoke tobacco, for example, are exposed to high
levels of the PAH benz[a]anthracene (Werley et al., 2008)
and show a 450% increased risk of developing SCC
(Leonardi-Bee et al., 2012). Mutagenic PAHs form stable,
bulky covalent DNA-PAH adducts that lead to double-
stranded DNA breaks and nucleic base mismatch reads. The
cellular handling and metabolism of PAHs are therefore
fundamental to understanding early events in chemical
carcinogenesis. Most prior studies, however, have focused
on the target epithelial cells of transformation, largely ignoring
the other locally resident cells that may have substantial
influence on these events.
Within the epidermis, a network of dendritic Langerhans
cells (LCs) extend to contact the vast majority of basal,
suprabasal, and infundibular keratinocytes, in which tumor
suppressor gene (e.g., p53) and oncogene (e.g., Ras) mutations
may precipitate squamous cell carcinomas (SCCs). Recently,
we demonstrated that LC-deficient (huLangerin-DTA trans-
genic; DTA (Kaplan et al., 2005)) mice are strikingly resistant
to two-stage chemical carcinogenesis, and to Hras muta-
genesis by dimethylbenz[a]anthracene (DMBA) (Modi et al.,
2012), despite the fact that the keratinocytes of such mice
contain all the requisite enzymes for metabolism of DMBA.
The abrogation of the requirement of LC for keratinocyte
genotoxicity and tumor induction after topical application of
the 3,4-diol DMBA metabolite implicated preferential
metabolism of DMBA by LC to reactive intermediates, over
detoxification. Consistent with this, murine LCs were found to
express cytochrome p450 enzyme CYP1B1, but not CYP1A1,
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and human LCs express markedly higher levels of CYP1B1
than of CYP1A1. Thus, we hypothesized that the high ratio of
CYP1B1:CYP1A1 within LC biased metabolism of DMBA to
mutagenic metabolites, inducing DNA damage and provoking
carcinogenesis in adjacent keratinocytes that themselves
expressed high levels of both p450 enzymes, but in the
inverse ratio (CYP1A14CYP1B1).
To further investigate the mechanisms by which LCs
facilitate chemical carcinogenesis, we herein studied the
kinetics of LC handling of DMBA and demonstrate that LCs
rapidly internalize and accumulate DMBA as numerous
membrane-independent cytoplasmic foci that are excluded
from LC nuclei. We developed a strategy for the repopulation
of LC-deficient mice using fetal liver LC-precursors, and
reestablished DMBA-induced tumor susceptibility, proportion-
ate to levels of LC reconstitution. By neonatal repopulation of
LC-deficient mice with fetal liver LC-precursors isolated from
CYP1B1-deficient donors, we reveal that LC expression of
CYP1B1 is required for maximal rapid induction of DNA
damage within adjacent keratinocytes, and as well as for their
efficient neoplastic transformation. Nonetheless, LCs also
show the capacity to mediate pro-carcinogenic effects inde-
pendently of CYP1B1. For example, consistent with a role for
LC in increasing the bioavailability of mutagen independently
of metabolism, mice repopulated with LC from CYP1B1 /
donors are more susceptible to DMBA-induced DNA damage
compared with LC-deficient mice. In addition, effects on
tumor progression attributable to the presence of LC were
revealed as CYP1B1 independent. Thus, LCs make multi-
faceted contributions to cutaneous carcinogenesis via their
handling and metabolism of chemical mutagens, as well as
their potentiation of tumor progression.
RESULTS AND DISCUSSION
LCs internalize DMBA and facilitate cutaneous carcinogenesis
Keratinocytes possess all the enzymatic requirements to
metabolize DMBA to mutagenic forms; yet, application of
DMBA followed by weekly promotion with the phorbol ester
12-O-tetradecanoylphorbol-13-acetate (TPA) much more
readily facilitates tumor outgrowth in the presence of LC
(Figure 1a). These data are consistent with mechanisms where
LCs enhance DMBA mutagenesis within adjacent epidermal
stem cells. Moreover, 24 hours after topical cutaneous expo-
sure to DMBA, we observed LC mRNA expression, surface
protein, and morphologic changes indicative of aryl hydro-
carbon receptor–mediated activation. In addition to our
previous observation of increased CYP1B1 expression (Modi
et al., 2012), the LC cell line XS106 also displayed mRNA
levels increased for CD80 and CD207 and decreased for TLR4
(Figure 1b). As well, 24 hours after percutaneous application
of DMBA, isolated LC displayed increased CD86 surface
protein (Figure 1c) and, in vivo, converted from a dendritic
to a more rounded morphology (Figure 1d and e). These
changes are all consistent with that previously reported for aryl
hydrocarbon receptor xenobiotic response element activation
in myeloid-derived cells (Simones and Shepherd, 2011;
Ilchmann et al., 2012). Thus, we sought to better understand
the characteristics of LC internalization of DMBA, and
monitored XS106, as well as isolated murine epidermal LC,
by time-lapse two-photon microscopy after in vitro exposure
to DMBA. The multi-ringed structures of PAHs provide
predictable spectral fluorescence properties, and DMBA
fluoresces in the 440 nm wavelength range upon excitation
with UV light. Two-photon microscopy systems using pulsed
femtosecond laser exposures provide high sensitivity with less
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Figure 1. Langerhans cells (LCs) facilitate dimethylbenz[a]anthracene
(DMBA)-initiated cutaneous carcinogenesis and display phenotypic and
morphologic changes in response to DMBA exposure. (a) Carcinogenesis
initiated in LC-intact (NLC) and LC-deficient (DTA) mice by application of
DMBA (400 nmole) followed by twice weekly 12-O-tetradecanoylphorbol-13-
acetate (TPA) (20 nmole, n¼ 13–15 mice per group, ***Pp0.001). (b) XS106
was treated with 64mM DMBA and changes in gene expression monitored by
quantitative real-time PCR, *Po0.05, **Pp0.01, ***Pp0.001. (c) FVB/N
dorsal bodywall was treated with vehicle (acetone) or 400 nmole DMBA, and
epidermal cell suspensions were prepared 24 hours later and stained for flow
cytometric analysis. Population shown is gated on CD45þ CD207þ cells.
LCs from untreated (not shown) and vehicle-treated mice had similar CD86
expression (DMFI¼ 20.4 vs 17.3; P¼ n.s.). LC CD86 expression increased
following DMBA treatment (DMFI¼ 54.4, P¼0.0013 vs vehicle, n¼ 3 mice/
group). (d, e) FVB/N dorsal ears were treated with 35 nmoles DMBA, and
epidermal sheets were prepared 24 hours later and stained with CD207
(red)þMHC II (green). LCs were identified and their shape factor (circularity
ranging from 0 to 1, circle¼1. Mean±SE untreated 0.1825±0.0019, DMBA
treated 0.2254±0.0028, Po0.0001) measured using Volocity 6.2, n¼3 mice
per group. Scale bar¼10mm.
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phototoxicity, and thus may be used to monitor PAH in live
cell systems. XS106 were observed to readily internalize
DMBA immediately after exposure, with increasing accumu-
lation evident as discrete intracellular foci over 1 hour, in all
cells observed (Figure 2a, Supplementary Movie S1 online).
LC isolated from murine skin, in contrast, showed an approxi-
mately 10 -minute delay in the appearance of intracellular
DMBA foci; yet, numbers of foci per cell accumulated with
rapid kinetics to reach levels comparable to that seen in
XS106 cells by 20 minutes after exposure (Figure 2a, Supple-
mentary Movie S2 online). Individual foci size increased over
time (Figure 2b) indicating intracellular concentration of
DMBA. One hour post DMBA exposure, high-resolution
z-stack confocal images of isolated LC and XS106 cells with
surface membranes labeled with antibodies to MHC II
(Figure 2c and d, Supplementary Figure S1 online) revealed
the internalized DMBA as numerous, variably sized foci that
were excluded from the nuclei. Consistent with the foci
representing cytoplasmic collections into hydrophobic micro-
droplets following transmembrane diffusion, there was no
evidence of endocytic vesicle formation or membrane-bound
containment of the DMBA by either MHC II (Figure 2c and d,
Supplementary Figure S1 online) or PKH26 red fluorescent
membrane tracking dye (Figure 2e). After a 1 hour exposure to
DMBA, isolated LCs that were transferred to fresh media
without DMBA showed persistent depots of internalized
DMBA, even after 24 hours (Figure 2f, Supplementary Movie
S3 online). Thus, LCs have the capacity for rapid intracellular
accumulation of DMBA. The delay in the appearance of
DMBA foci within isolated LC (relative to that within XS106)
suggests that normal LC may utilize an activated diffusion
prior to the more passive diffusion, whereas the complete
absence of MHC II-containing membranes and PKH26 around
the DMBA foci indicates that this internalization is not the
result of endocytosis. Furthermore, the observed nuclear
exclusion is consistent with cellular processes that may protect
against LC’s own genotoxicity.
Embryonic LC-precursors repopulate the skin of neonatal
LC-deficient mice
Taken together, the observed characteristics of LC handling
of DMBA (Figures 1 and 2) suggest LC enhancement of
epidermal carcinogenesis by DMBA internalization, focal
concentration, aryl hydrocarbon receptor-driven expression
of metabolizing CYP1B1, and potential transfer of mutagenic
metabolites to adjacent keratinocytes. Consistent with this, we
previously demonstrated that DMBA applied to the skin
resulted in higher rates of epidermal cell DNA damage and
increased tumor formation in LC-intact mice relative to
LC-deficient mice (Modi et al., 2012). To better elucidate
the previously observed capacity of LC to facilitate epidermal
cell genotoxicity and enhance tumor development, we
developed a strategy for the efficient repopulation of LC
within LC-deficient mice. Recently, it was identified that
LC-progenitors first derive as an F4/80bright macrophage-
precursor population within the embryonic yolk sac, emerg-
ing around embryonic age day (E) 10 to seed the primitive skin
directly, or to first expand within the E10-14 liver, prior to
seeding and expanding in the embryonic skin (Hoeffel et al.,
2012; Schulz et al., 2012). Therefore, we hypothesized that
E10.5 yolk sac and E12.5 liver mononuclear cells when
injected intraperitoneally into LC-deficient mice would seed
the skin and expand to repopulate the LC compartment by
adulthood, as we and others have demonstrated previously for
skin repopulation of dendritic epidermal T cells using E14-17
thymocytes (Havran and Allison, 1990; Payer et al., 1991;
Girardi et al., 2002). In fact, both E10.5 yolk sac and E12.5
liver LC precursors were capable of repopulating the
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Figure 2. Langerhans cells (LCs) rapidly internalize dimethylbenz[a]anthracene
(DMBA) as intracellular foci. (a) DMBA (64mM) was added to the LC cell line,
XS106, or isolated LC and DMBA fluorescence followed using two-photon
microscopy and time-series images collected every 2 minutes (XS106,
Supplementary Movie S1 online) or 2.5 minutes (LC, Supplementary Movie S2
online) over 1 hour. DMBA foci within individual cells (n¼ 148 XS106, n¼ 81
LC) were identified and quantitated over the first 25 minutes using ImageJ. (b)
Individual foci identified within XS106 during the first 10 minutes of DMBA
exposure were measured and followed using ImageJ. (c) Compressed z-stack of
isolated LC (FITC-MHC II, green) following 1 hour DMBA (blue) exposure. Single
slices of z-stack (Supplementary Figure S1 online) suggest nuclear exclusion of
DMBA foci. (d) XS106 cells were labeled with FITC-MHC II (green) and the
nuclear dye CyTRAK Orange (red) then exposed to DMBA (blue) for 1 hour.
DMBA foci were excluded from the nucleus. (e) XS106 cells were labeled with
the membrane dye PKH26 (red) then exposed to DMBA (blue) for 1 hour.
(f) Isolated LCs were exposed to DMBA for 1 hour, then washed and cultured for
an additional 23 hours in the absence of DMBA (Supplementary Movie S3
online). At this time, 42% of LCs retained at least 1 DMBA focus, exemplified in
the single slice of the z-stack shown.
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epidermis when transferred into newborn LC-deficient DTA,
with the E12.5 liver showing slightly greater efficiency
(Figure 3a). Notably, 3 weeks following transfer, LCs were
observed as circular expanding populations in the recipient
epidermis (Figure 3b, and by 8 weeks eventually filled the
epidermis of adult recipients (Supplementary Figure S2
online). These observations provide insight into the normal
physiologic population of the epidermis by LC precursors
present within embryonic yolk sac (Schulz et al., 2012) and
embryonic liver (Hoeffel et al., 2012), and the ‘‘seed–soil’’
relationship of precursors that can expand over weeks after
seeding the immature skin.
To examine the effect of recipient age at the time of transfer
on the ability of precursors to enter the epidermis and expand,
E12.5 liver-derived LC-precursors were injected intraperitone-
ally into LC-deficient recipients ranging in age from o36
hours to 5 weeks, and the resulting epidermal LC populations
analyzed and compared with age-matched normal controls.
LCs were reestablished most efficiently when transferred into
newborn recipients (Figure 3c) and displayed phenotypic
(Figure 3d) and morphologic (Figure 3e) characteristics of
normal LC. The requirement for neonatal skin, with marked
decreasing efficiency of LC repopulation in recipients 436-
hour old, is in contrast to our experience with repopulation of
dendritic epidermal T cell where E16 thymocyte precursors
will repopulate adult epidermis provided the skin is in active
hair growth at the time of transfer (Supplementary Table S1
online).
CYP1B1 expression by LC is required for maximal genotoxicity
of adjacent keratinocytes and tumor development
Despite the fact that keratinocytes express the enzymes
(CYP1A1, CYP1B1, and epoxide hydrolase) necessary to
metabolize DMBA to its ultimate mutagenic form, DMBADE,
we previously proposed that the higher ratio of CYP1A1:-
CYP1B1 within keratinocytes favors detoxification (Modi
et al., 2012). Given the capacity of LC to internalize and
accumulate DMBA (Figures 1 and 2), and our previous
demonstration of the capacity of LC to metabolize DMBA to
its penultimate mutagenic form, DMBA-3,4-diol, we hypo-
thesized that CYP1B1 expression within LC would be required
for maximal genotoxicity of adjacent keratinocytes after
epidermal exposure to DMBA. Thus, we repopulated
LC-deficient mice with E12.5 liver LC-precursors from
CYP1B1 / mice (courtesy of F. Gonzalez; Buters et al.,
1999), which we first backcrossed to the FVB background
by speed congenic breeding, and compared them to LC-
deficient mice repopulated with precursors from wild-type
(w.t., CYP1B1-competent) FVB mice. LC repopulation levels
and LC surface phenotype and morphology were equivalent in
DTA recipients of w.t. or CYP1B1 / LC precursors
(Figure 3c–e).
Phosphorylated (g)H2Ax is recruited to double-stranded
DNA breaks and DNA-PAH adducts and is therefore a
nonspecific but sensitive indicator of DNA damage, including
that as a result of DMBA exposure (Modi et al., 2012). Twenty-
four hours after a single application of DMBA, LC-deficient
mice repopulated with LC-precursors from wild-type mice
showed levels of gH2Ax comparable to that of wild-type mice
(Figure 4a and b). Thus, repopulation of LC by intraperitoneal
injection of embryonic liver isolated LC-precursors into
neonatal recipients results by adulthood in functionally com-
petent LC, capable of facilitating keratinocyte genotoxicity
after DMBA exposure. In contrast, LC-deficient mice repopu-
lated with LC-precursors from syngeneic CYP1B1 / mice
showed significantly reduced levels of gH2Ax relative to
LC-intact controls but which were statistically distinguishable
from that of mice devoid of all LCs (Figure 4a and b).
Therefore, CYP1B1 expression specifically within LC contri-
butes substantially to neighboring keratinocyte DNA damage
following DMBA exposure, even though this DMBA metabo-
lizing enzyme is present in the surrounding cells. In addition,
the observation that DTA mice repopulated with CYP1B1 /
LC had increased DNA damage compared with mice devoid
of all LCs indicates that LCs also participate in CYP1B1-
independent events that facilitate damage of surrounding cells.
Within each of the DMBA-exposed groups, onlyB1% of LCs
showed gH2AX staining indicative of DNA damage, whereas
LC density 24 hours post DMBA exposure was not distinguish-
able from that of untreated mice (Supplementary Table S2
online). This, together with the observed lack of nuclear
DMBA fluorescence within LC (Figure 2d), suggests that LC
may possess mechanisms to guard against their own geno-
toxicity while contributing to adjacent keratinocyte damage.
When groups of LCs repopulated and control mice were
followed for tumor development using the standard DMBA-
TPA model, LC-deficient mice repopulated with LC-precursors
from wild-type embryos were again similar to normal FVB
(LC-intact) mice (Figure 5a–c), and the level of LC reconstitu-
tion measured at 8 weeks, i.e., immediately prior to initiation
with DMBA, was directly correlated with the extent of
tumor development (R¼ 0.7528; P¼ 0.0155, data not shown).
Figure 3. Embryonically derived Langerhans cells (LC)-precursors repopulate LC-deficient huLangerin-DTA transgenic Langerhans cell deficient mouse (DTA)
mice. (a) Cell suspensions prepared from w.t. E10.5 yolk sac or E12.5 liver were injected i.p. into newborn LC-deficient DTA recipients. Three or eight weeks later,
flow cytometric analysis of epidermal cell suspensions prepared from recipients as well as LC-intact (NLC) and DTA controls were used to determine the extent of
LC repopulation. (b) Immunofluorescent staining of an epidermal sheet prepared from a DTA recipient 3 weeks following E12.5 liver transfer shows expanding
groups of LC (CD207, green). Scale bar¼ 500mm. Inset scale bar¼100mm. (c) E12.5 liver suspensions prepared from w.t. or CYP1B1 / donors were injected
i.p. into recipients of indicated ages. Epidermal cell suspensions prepared 8 weeks later and analyzed by flow cytometry show decreasing LC repopulation with
increasing recipient age at the time of transfer. No repopulation was detectable when recipients were 5 weeks old at transfer. (d) Flow cytometric analysis of
epidermal cell suspensions prepared from bodywall skin of 8-week-old NLC, DTA, and DTA recipients of E12.5 liver. Upper panels are gated on total epidermal
cells; lower panels are gated on CD45þ cells. (e) Epidermal sheets prepared from bodywall skin 8 weeks following E12.5 liver transfer show typical LC (CD207,
green) and dendritic epidermal T cell (TCRgd, red) density and morphology when examined by confocal microscopy. Scale bar¼ 10mm.
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In contrast, LC-deficient mice repopulated with CYP1B1-
deficient LC precursors were indistinguishable by tumor area
per mouse (Figure 5a) or tumor area/tumor-bearing mouse
(Supplementary Table S3 online) from LC-deficient control
DTA mice through 12 weeks of tumor promotion, and showed
markedly reduced tumor susceptibility relative to LC-deficient
mice repopulated with w.t. LC precursors and NLC (w.t.)
controls (Figure 5a–c).
However, tumors in DTA mice repopulated with
CYP1B1 / LC did arise earlier than in DTA controls
(Figure 5c). This suggested that LC exerted CYP1B1-indepen-
dent effects on tumor promotion. Therefore, we continued to
follow co-caged cohorts of DTA and DTA repopulated with
CYP1B1 / LC. Notably, tumor growth was observed to
statistically increase in CYP1B1-deficient LC-repopulated
mice, relative to LC-deficient controls at 14 weeks, further
suggesting a CYP1B1-independent tumor-promoting role for
LC (Figure 5d and e). Consistent with this, independent studies
in DMBA-naive mice showed increased epidermal hyperpla-
sia in LC-intact skin relative to LC-deficient skin after repeated
exposure to TPA alone (Figure 5f) and increased ear thickness
48 hours following a single application of TPA (Figure 5g).
Each of these results suggests that LCs influence the response
to epidermal perturbation, directly or indirectly promoting
eventual keratinocyte proliferation that is fundamental to
tumor promotion.
Collectively, our data reveal multiple distinct roles for LC in
chemical carcinogenesis: (1) morphologic and structural
features that support efficient PAH internalization and collec-
tion within LC, (2) metabolism to mutagenic metabolites that
are specifically dependent on LC expression of CYP1B1, and
(3) CYP1B1-independent contributions to DNA damage within
adjacent keratinocytes and to tumor promotion. The contribu-
tions of immune cells to tumor growth have been previously
characterized to include the activities of tumor-associated
macrophages, tumor-promoting T cells (Kwong et al., 2010),
and T-regulatory cells that may increase oxidative stress,
provide growth factors, and suppress anti-tumor immunity to
facilitate tumor immune evasion and growth. We have
extended these untoward effects of immune cells under the
concept of cooperative carcinogenesis to emphasize that
immune cells may be fundamental to the full spectrum of
initiation and promotion.
Major lines of epidemiologic and experimental study have
linked mutagenic PAHs to cancer within a variety of tissues
(e.g., skin, lung, gastrointestinal, bladder, and breast) (Boffetta
et al., 1997; Armstrong et al., 2004). In addition, a role for
mutagenic PAHs in cutaneous carcinogenesis, including their
potentiation of UVR, has been implicated by several lines of
laboratory investigation. Purified particles of air pollution
applied to the skin of mice can serve as an initiator of
cutaneous carcinogenesis, and this is dependent on the
expression of the intracellular aryl hydrocarbon receptor for
PAHs (Matsumoto et al., 2007). Initiation by topical
application of mutagenic benzo[a]pyrene followed by
exposure to UV radiation synergistically provokes skin tumor
formation in mice (Burke and Wei, 2009). Furthermore,
chronic exposure of mice to both inhalation of PAH-
containing tobacco smoke and UV radiation induces the
outgrowth of cutaneous SCC at a much greater rate
compared with either agent alone (Pavlou et al., 2009). A
single application of the PAH 7,12-DMBA prior to UV
radiation of human skin xenografts markedly increases the
development of actinic keratoses and SCC, relative to the
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same dose of UV alone (Berking et al., 2002). Thus, although
UV radiation is well established as a genotoxic agent
associated with human skin cancer risk, these studies
collectively reveal the potential of chemical mutagenesis by
PAHs as an underappreciated cofactor in the induction of
human cutaneous malignancy.
SCSs constitute the most common human solid tumor
malignancy including those of the skin, gastrointestinal,
genitourinary, breast, and lung origins. They derive, by
definition, from continuously regenerating epithelial cells that
encompass large surface areas at the interface with the
environment, where they may be exposed to myriad environ-
mental compounds, including mutagenic PAHs. In addition to
direct contact with exogenous agents of DNA-damaging
potential, systemic absorption of such mutagens through the
epithelium (e.g., via smoking, industrial exposures, diets high
in grilled meats) can lead to more global tissue exposures. As
CYP1B1 has also been shown to metabolize the carcinogenic
PAH benzo[a]pyrene to its mutagenic intermediate (Shimada
et al., 1999), and an elevated CYP1B1:CYP1A1 ratio has
been reported in human monocyte/macrophage subsets
(Baron et al., 1998), it is conceivable that a spectrum of
benz[a]athracene and benzo[a]pyrene-related compounds
present in the environment might be predicted to undergo
similar handling and activation within the skin and other
tissues.
Moreover, it is also possible that differential cellular
expression of metabolizing enzymes other than CYP1B1 may
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Figure 5. Langerhans cell (LC) expression of CYP1B1 is required for optimal cutaneous chemical carcinogenesis. (a) Chemical carcinogenesis was initiated in LC-
intact (NLC) and huLangerin-DTA transgenic Langerhans cell deficient mouse (DTA) controls as well as DTA repopulated with either w.t. or CYP1B1 / LC
using 400 nmoles dimethylbenz[a]anthracene (DMBA) followed by twice weekly 12-O-tetradecanoylphorbol-13-acetate (TPA) promotion (20 nmole); ***Po0.001
DTAþCYP1B1 / LC vs DTAþw.t. LC and vs NLC; and Po0.001 for DTA vs DTAþw.t. LC and vs NLC. N¼5–15 mice/group for panels a–c. (b)
Representative images from (a) taken 12 weeks following initiation. (c) The percentage of tumor-free mice over time depicted in Kaplan–Meier plot. Po0.05 for
DTA vs DTAþCYP1B1 / LC, Pp0.01 for DTAþCYP1B1 / LC vs DTAþw.t. LC and vs NLC, Po0.0001 for DTA vs NLC and vs DTAþw.t. LC. (d, e)
Fourteen weeks post initiation, DTA repopulated with CYP1B1 / LC have more total tumors (d) and carcinomas (e) compared with LC-deficient DTA; n¼ 7
DTA, 5 DTAþCYP1B1 / LC. (f) Epidermal hyperplasia, as measured by minimal epidermal thickness, in response to repeated TPA application (4 weeks) is
greater in the presence of LC; n¼5 DTA, 5 NLC. (g) Ear thickness 48 hours after a single TPA application is greater in the presence of LC; n¼ 6 DTA, 8 NLC.
Baseline ear thickness (g) and minimal epidermal thickness (f) are not different in DTA vs NLC. *Po0.05, **Pp0.01, ***Pp0.001. Each dot represents one mouse
in panels d–g.
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also contribute to carcinogenesis. For example, LC also
preferentially expresses CYP2E1 (Saeki et al., 2002) which
has the capacity to activate several carcinogens including
benzene (Valentine et al., 1996) and azoxymethane (Sohn
et al., 2001). Thus, although we believe our findings defini-
tively demonstrate that LC expression of CYP1B1 is funda-
mental to DMBA mutagenesis of neighboring keratinocytes,
further investigation is warranted to fully appreciate the
potential generalizability to other dendritic cell populations,
other metabolizing enzymes, and other epithelial and non-
epithelial tissues.
The roles (beyond antigen presentation) of Langerhans cells
in cutaneous biology have been expanded to also include
their potential for immune regulation (Kaplan et al., 2005). As
initiation effects of LC are independent of adaptive immunity
(i.e., occurring in the absence of all T cells; Strid et al., 2008;
Modi et al., 2012), it is unlikely that T cell–mediated
regulation has a significant role in this stage of chemical
carcinogenesis. In contrast, the previously described tumor-
promoting ab T cells and anti-tumor gd T cells (Girardi et al.,
2001, 2003; Roberts et al., 2007; Kwong et al., 2010) raise the
possibility that these components of adaptive immunity may
interact with LC to, in aggregate, contribute to tumor pro-
motion. In this regard, application of higher doses of DMBA
(or UV light) to mouse skin results in depletion of LC largely
due to migration to draining lymph nodes, and percutaneous
immunization in such mice shows blunted antigen-specific
responses that might include anti-tumor effects (Ragg et al.,
1995; Qu et al., 1997). Thus, although we have herein pro-
vided additional insight into mechanisms by which LCs
influence chemical carcinogenesis, further studies are necessary
to more clearly delineate the complexity of interactions
between LC and other immune cells in regulating tumor
promotion.
MATERIALS AND METHODS
Animals and housing
Mice were maintained under specific pathogen-free conditions in a
facility accredited by the Association for Assessment of Laboratory
Animal Care with food and water provided ad libitum. The Yale
Animal Care and Use Committee approved all in vivo studies. FVB/N
mice were purchased from The Jackson Laboratory. FVB/N LC–
deficient (DTA) mice were generated with a bacterial artificial
chromosome–based transgene containing human Langerin modified
to drive expression of diphtheria toxin subunit A from an internal
ribosome entry site inserted in the 30 untranslated region of the
langerin gene (Kaplan et al., 2005). Cyp1b1 / mice were kindly
provided by F. Gonzalez (NCI, Bethesda, MD) and backcrossed onto
the FVB background via speed congenic methodology (testing
provided by IDEXX RADIL, Columbia, MO) for six generations.
DMBA fluorescence
The LC-like cell line XS106 was kindly provided by A. Takashima
(U of Toledo, OH) and cultured as previously described (Modi et al.,
2012). Epidermal cell suspensions were prepared as previously
described (Strid et al., 2008) and LC enriched using either MHC II-
or CD45-magnetic beads (Miltenyi Biotec, San Diego, CA) followed
by staining with PE or FITC-MHC II (eBioscience, San Diego, CA) and
MoFlo (DAKO, Carpinteria, CA) cell sorting to obtain 98% purity.
XS106 or purified LCs were cultured overnight in 35 mm glass bottom
culture dishes (MatTek Corp, Ashland, MA) in phenol red-free RPMI
1640 (Invitrogen, Grand Island, NY) containing 10% FBS, 10 mM
Hepes, 1% nonessential amino acids, 2 mM L-glutamine, 1 mM
sodium pyruvate, 0.05 mM b-mercaptoethanol, and antibiotics
before use in DMBA fluorescence monitoring. DMBA (Sigma, St
Louis, MO; 64mM) was added after images of untreated cells were
collected. Imaging was performed using a Zeiss (Oberkochen,
Germany) 710 Duo NLO/Multiphoton microscope running Zen
2010 software and equipped with a Spectra-Physics MaiTai
titanium:sapphire laser for two-photon excitation, and an enclosed
CO2 incubator (37 1C). DMBA fluorescence was collected from 400
to 490 nm (peak 440 nm). In some experiments FITC or PE-MHC II
(eBioscience) antibody was added (0.25mg ml 1) to permit LC cell
membrane visualization. XS106 was labeled with CyTRAK Orange
(5mM, eBioscience) or membrane dye PKH26 (Sigma) according to
the manufacturer’s instructions and exposed to DMBA (16mM) for 1
hour before z-stacked images were obtained. Live time-series images
were taken every 2 or 2.5 minutes over 1 hour. Individual cells and
contained DMBA foci were identified and quantitated using ImageJ
v1.47 (NIH).
Confocal microscopy
Epidermal sheets were prepared following a 2 hour 37 1C incubation
in 20 mM EDTA (for LC morphology post DMBA application and LC
and dendritic epidermal T cell visualization in repopulated mice) or a
20 minute 37 1C incubation in 0.5 M ammonium thiocyanate (for
gH2AX analysis), fixed 20 minutes in ice-cold acetone, rehydrated in
PBS, blocked with 2% BSA, and stained using the following
antibodies: anti-CD207 (1.5mg ml 1, RMUL.2, eBioscience)þ
Alexa488- or Cy3-Donkey-anti-rat IgG (Jackson Immunoresearch,
West Grove, PA), anti-TCRgd (1.5mg ml 1, GL3, Becton Dickinson,
San Jose, CA)þCy3-goat anti-hamster IgG (Jackson Immunoresearch),
anti-gH2AX (1mg ml 1, JBW30, Millipore, Billerica, MA)þ
Alexa568-Goat-anti-mouse IgG (Invitrogen), and FITC-MHC II
(1.6mg ml 1, M5/114.15.2, Biolegend, San Diego, CA). Samples
were examined using a Zeiss 510Meta confocal microscope. Analysis
of gH2AXþ cells was performed as previously described (Modi et al.,
2012). Briefly, 35 nmole DMBA was applied to the dorsal surface of
each ear, and 24 hours later epidermal sheets were prepared, stained,
and z-stacked images of 10 fields per sheet (2 sheets per mouse)
collected in a set pattern in 2 mm intervals. ImageJ (NIH) particle
analyzer software was used to identify and quantitate gH2AXþ cells.
For analysis of LC morphology 24 hours post DMBA application,
images collected as described above were analyzed using Volocity
6.2 (Perkin Elmer, Waltham, MA) for LC identification and
measurement of shape factor (circularity on a scale of 0–1 with 1¼
circle). The mean and distribution of shape factor measurements were
calculated using Prism 6.0 (GraphPad, La Jolla, CA).
Gene expression analysis
RNA was isolated from XS106 cells using the RNeasy Micro
kit (Qiagen, Valencia, CA) and transcribed using the High-
Capacity cDNA Reverse Transcription kit (ABI, Carlsbad, CA). Real-
time quantitative RT-PCR (ABI 7500, SDS 2.0 software) was per-
formed using Taqman assays and Taqman Gene Expression Master-
mix (ABI). Obtained Ct values were normalized to b-actin and
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expression differences to untreated samples calculated using
RQ¼ 2DDCt.
Flow cytometric analysis
To examine LC phenotype following DMBA exposure, epidermal cell
suspensions were prepared as previously described (Strid et al., 2008)
from dorsal bodywall of FVB/N mice that had been clipped and
treated with depilatory cream 5 days earlier and treated with vehicle
(acetone) or DMBA (400 nmole) 24 hours before harvest. After
blocking FcR (CD16/32), cells were stained with PerCPCy5.5-
CD45, PE-MHC II, APC-CD86 (all from eBioscience), and
Alexa488-CD207 (Imgenex, San Diego, CA) and data collected
using FACSCalibur (Becton Dickinson) and analyzed with FlowJo
(TreeStar, Ashland, OR). To assess LC repopulation levels, epidermal
cell suspensions were prepared from either ear punch biopsy (prior to
DMBA application in carcinogenesis studies) or from untreated
bodywall skin. Epidermal cells from LC-intact (NLC) and LC-
deficient (DTA) as well as those from each repopulated mouse were
blocked (CD16/32) and stained with APC-CD45þ PE-MHC
IIþAlexa488-CD207. In each experiment the average percentage
of CD45þMHC IIþCD207þ epidermal cells in NLC controls was
calculated and the percent LC repopulation of each individual yolk
sac or liver recipient determined by comparison.
LC repopulation
E10.5 yolk sac or E12.5 liver was isolated from donor embryos.
Yolk sac was digested as described (Morgan et al., 2008)
by incubation in 0.25% collagenase in PBS containing 20%
FBS for 40–60 minutes at 37 1C. Liver was dissociated by gentle
pipetting. Cells were washed once in PBSþ 10% FBS and
resuspended in PBS at 4 donor equivalents per 30ml. Newborn
LC-deficient recipients received 30ml donor cells by intraperitoneal
injection. The level of LC repopulation was assessed by flow
cytometric analysis.
Two-stage chemical carcinogenesis
As previously described (Modi et al., 2012) at age 7 weeks, dorsal
bodywall hair was removed by shaving with electric clippers
followed by application of depilatory cream. One week later
carcinogenesis was initiated by application of DMBA (400 nmole,
Sigma) in acetone. One week following initiation, twice weekly
applications of TPA (20 nmole, Sigma) in ethanol began. Tumors
were counted, measured, and scored weekly as clinically apparent
papillomas (i.e., well demarcated, symmetrical, pedunculated, or
dome-shaped papules, without erosion or ulceration) or clinically
apparent carcinomas (poorly demarcated, asymmetrical, non-
pedunculated, or dome-shaped papules with erosion or ulceration)
by an observer blinded to the experimental groups, as previously
described (Girardi et al., 2003). After 12 weeks of promotion, tumor
burden was a humane concern for NLC and DTAþw.t. LC groups,
therefore, only co-caged cohorts of DTA and DTAþCYP1B1 /
LC groups were carried through 14 weeks. At the conclusion of
experiments, representative tumors were excised, fixed, and
embedded for hematoxylin and eosin staining and were examined
by a certified dermatopathologist (C.K.) for histologic confirmation.
The terms ‘‘tumor area’’ and ‘‘tumor number’’ are used to refer to all
tumors present (papillomasþ carcinomas).
Irritant responses
For analysis of epidermal hyperplasia, TPA (20 nmole) in ethanol was
applied to dorsal bodywall skin twice weekly for 4 weeks, then
formalin fixed paraffin-embedded samples prepared, stained with
hematoxylin and eosin, and examined using an Olympus BH10
microscope equipped with an optical micrometer. Minimal epidermal
thickness was measured from the basal to the granular layer of the
epidermis in 12 fields per section in 4 samples per mouse. Ear
thickness following a single application of TPA (0.5 nmole to each
side of each ear) was measured using an engineer’s micrometer
(Mitutoyo 7301). Measurements were made by an observer blind to
the experimental groups.
Statistical analysis
One-tailed Student’s t-test for unpaired data was used to determine
the statistical significance of difference between experimental groups
in all cases, except Figure 1a, b, and d and Figure 5a and c, with
significance at Po0.05. Curves in Kaplan–Meier plots (Figure 5c)
were compared using the log-rank test. Changes in tumor area or
gene expression over time (Figure 1a and b and Figure 5a) were
compared using repeated-measures ANOVA with appropriate correc-
tion for multiple time point and multiple group comparisons (Tukey’s
correction for Figure 5a, Sidak’s correction for Figure 1a and b).
Frequency distributions (Figure 1d) were compared with the non-
parametric Kolmogorov–Smirnov test. All statistical analyses were
performed with GraphPad Prism 6.0 software.
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